Tumor Microenvironment
"Tumor Microenvironment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth.
| Descriptor ID |
D059016
|
| MeSH Number(s) |
G04.366.500
|
| Concept/Terms |
Tumor Microenvironment- Tumor Microenvironment
- Microenvironment, Tumor
- Microenvironments, Tumor
- Tumor Microenvironments
Cancer Microenvironment- Cancer Microenvironment
- Cancer Microenvironments
- Microenvironment, Cancer
- Microenvironments, Cancer
|
Below are MeSH descriptors whose meaning is more general than "Tumor Microenvironment".
Below are MeSH descriptors whose meaning is more specific than "Tumor Microenvironment".
This graph shows the total number of publications written about "Tumor Microenvironment" by people in this website by year, and whether "Tumor Microenvironment" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 | | 2012 | 2 | 1 | 3 | | 2013 | 2 | 7 | 9 | | 2014 | 0 | 2 | 2 | | 2015 | 7 | 3 | 10 | | 2016 | 8 | 6 | 14 | | 2017 | 3 | 14 | 17 | | 2018 | 7 | 13 | 20 | | 2019 | 15 | 21 | 36 | | 2020 | 15 | 30 | 45 | | 2021 | 7 | 38 | 45 | | 2022 | 1 | 41 | 42 | | 2023 | 4 | 43 | 47 | | 2024 | 15 | 37 | 52 | | 2025 | 13 | 28 | 41 | | 2026 | 10 | 17 | 27 |
To return to the timeline, click here.
Below are the most recent publications written about "Tumor Microenvironment" by people in Profiles.
-
Cheng K, Nie H, Zhou W, Guo D, Liao L, Zhang X, Wang C, Zielinski RJ, Gavade JN, Sriramkumar S, Fang Y, Xia S, Wu S, Tang HY, Kossenkov AV, Qi Y, Liu J, Le K, Gruber D, Soth MJ, Post MD, Sood AK, Flückiger-Mangual S, Yap TA, Bitler BG, Zhang R. Targeting p300 Reverses Acidic Microenvironment-Induced PARP Inhibitor Resistance. Cancer Res. 2026 Oct 02; 86(19):4934-4954.
-
Li W, Grieshober L, Gertz J, Ivich A, Doherty JA, Greene CS, Hicks SC. Characterizing intra- and intertumor heterogeneity in ovarian high-grade serous carcinoma subtypes using single-cell and spatial transcriptomics. Genome Res. 2026 Oct 01; 36(10):2011-2026.
-
Weaver AN, Keysar SB, Dureja A, Chimed TS, Le PN, Nieto C, Alzofon N, Morton JJ, Thomas CM, Lanning RM, Samedi VG, Van Bokhoven A, Jimeno A. Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes. Cancer Res Commun. 2026 Oct 01; 6(10):2350-2359.
-
Valença-Pereira F, Johnson B, DeGregori J, Rincon M. Does acute inflammation triggered by infection promote cancer progression? PLoS Biol. 2026 Sep; 24(9):e3003962.
-
Nadorp B, Lasry A, Loghavi S, Patel R, Mansour H, Rovatti PE, Kelly BJ, Walker CJ, Buss J, Boateng I, Al-Santli W, Ciantra Z, Austin R, Desai H, Abaza H, Procell L, Patel T, Kaffenberger B, Wijeratne S, Guillamot M, Velegraki M, Chiriboga LA, Li Z, Pollyea DA, McMahon CM, Shanaah A, Byrd JC, Esteller M, Papapetrou EP, Tsirigos A, Mims AS, Mardis ER, Aifantis I, Eisfeld AK. RAS Pathway Activation and Microenvironmental Adaptation as Hallmarks of Myeloid Sarcoma. Blood Cancer Discov. 2026 Sep 03; 7(5):759-773.
-
Sharma JR, Singh V, Kandhari K, Agraval H. From smoke to stemness: Mechanisms of cancer stem cell induction by cigarette smoke. Biochim Biophys Acta Rev Cancer. 2026 Oct; 1881(5):189700.
-
Mikeska RG, Feldman LER, Woodruff ER, Iwanaga R, Linder KE, Yamamoto TM, Sompel K, Jordan KR, Post MD, Zoller M, Bitler BG, Marjon NA. Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma. Cancer Res Commun. 2026 Sep 01; 6(9):2256-2270.
-
Lingo JJ, Reis R, Koyas A, Voigt E, Zacharias ZR, Allamargot C, Hornick EL, Raygoza Garay JA, Kaemmer CA, Elias EC, Jabbari A, Wilhelm CR, Boyden AW, Karandikar NJ, Breheny P, Meyerholz DK, Dodd RD, Houtman JCD, Darbro BW, Quelle DE. Intratumoural plasma cells mediate a pro-inflammatory response to kinase inhibition and successful immune checkpoint blockade therapy in malignant peripheral nerve sheath tumours. EBioMedicine. 2026 Sep; 131:106413.
-
Padilla MS, Li JJ, Zhang Q, Patwari K, Shi S, Yamagata HM, Joseph RA, Hymms BN, Teerdhala SV, Fitzgerald E, Chalom OZ, Gupta K, Alameh MG, Weissman D, Le AD, Mitchell MJ. Lipid Nanoparticle Co-Delivery of mRNA and a Small Molecule Drug for Oral Cancer Chemoimmunotherapy. Adv Mater. 2026 Aug; 38(47):e73721.
-
Kane GI, Diaz-Infante MB, Wigglesworth K, Lusi E, Brassil M, Rozen EJ, Kady J, Mori H, Lukas J, Naylor T, Dinnell RW, Murphy KC, Alarcon CBB, Ruscetti M, Brehm M, Shohet JM, Atukorale PU. Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk Neuroblastoma. Mol Cancer Ther. 2026 Jul 02; 25(7):1144-1156.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|